Amina Ghouzlani

Casablanca, 20000, Morocco

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses.

Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses.

Journal: Immune network

Published: August 04, 2024

Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches.

Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches.

Journal: Frontiers in immunology

Published: March 12, 2024

High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas.

High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas.

Journal: Frontiers in immunology

Published: March 07, 2024

A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma.

A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma.

Journal: International journal of molecular sciences

Published: January 13, 2023

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.

NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma.

Journal: Frontiers in immunology

Published: January 06, 2023

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas.

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas.

Journal: Frontiers in oncology

Published: December 31, 2022

CAR T-cells for colorectal cancer immunotherapy: Ready to go?

CAR T-cells for colorectal cancer immunotherapy: Ready to go?

Journal: Frontiers in immunology

Published: June 25, 2022

Immune Checkpoint Inhibitors in Human Glioma Microenvironment.

Immune Checkpoint Inhibitors in Human Glioma Microenvironment.

Journal: Frontiers in immunology

Published: March 11, 2021

The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis.

The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis.

Journal: Scientific reports

Published: December 31, 2020

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis.

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis.

Journal: Frontiers in oncology

Published: September 22, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026